179 related articles for article (PubMed ID: 35543764)
1. The effects of two gold-N-heterocyclic carbene (NHC) complexes in ovarian cancer cells: a redox proteomic study.
Massai L; Messori L; Carpentieri A; Amoresano A; Melchiorre C; Fiaschi T; Modesti A; Gamberi T; Magherini F
Cancer Chemother Pharmacol; 2022 Jun; 89(6):809-823. PubMed ID: 35543764
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: a comparative proteomic study.
Magherini F; Fiaschi T; Valocchia E; Becatti M; Pratesi A; Marzo T; Massai L; Gabbiani C; Landini I; Nobili S; Mini E; Messori L; Modesti A; Gamberi T
Oncotarget; 2018 Jun; 9(46):28042-28068. PubMed ID: 29963261
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C
Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M
ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298
[TBL] [Abstract][Full Text] [Related]
6. A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis.
König P; Zhulenko R; Suparman E; Hoffmeister H; Bückreiß N; Ott I; Bendas G
Cancer Chemother Pharmacol; 2023 Jul; 92(1):57-69. PubMed ID: 37272932
[TBL] [Abstract][Full Text] [Related]
7. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
8. An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells.
Meier-Menches SM; Neuditschko B; Zappe K; Schaier M; Gerner MC; Schmetterer KG; Del Favero G; Bonsignore R; Cichna-Markl M; Koellensperger G; Casini A; Gerner C
Chemistry; 2020 Dec; 26(67):15528-15537. PubMed ID: 32902006
[TBL] [Abstract][Full Text] [Related]
9. Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A.
Curran D; Müller-Bunz H; Bär SI; Schobert R; Zhu X; Tacke M
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751607
[No Abstract] [Full Text] [Related]
10. Rationally Designed Redox-Active Au(I) N-Heterocyclic Carbene: An Immunogenic Cell Death Inducer.
Sen S; Hufnagel S; Maier EY; Aguilar I; Selvakumar J; DeVore JE; Lynch VM; Arumugam K; Cui Z; Sessler JL; Arambula JF
J Am Chem Soc; 2020 Dec; 142(49):20536-20541. PubMed ID: 33237764
[TBL] [Abstract][Full Text] [Related]
11. N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery.
Niu W; Chen X; Tan W; Veige AS
Angew Chem Int Ed Engl; 2016 Jul; 55(31):8889-93. PubMed ID: 27311814
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and biological studies of multidentate gold(i) and gold(iii) NHC complexes.
Bauer EB; Bernd MA; Schütz M; Oberkofler J; Pöthig A; Reich RM; Kühn FE
Dalton Trans; 2019 Nov; 48(44):16615-16625. PubMed ID: 31657405
[TBL] [Abstract][Full Text] [Related]
13. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors.
Rubbiani R; Salassa L; de Almeida A; Casini A; Ott I
ChemMedChem; 2014 Jun; 9(6):1205-10. PubMed ID: 24677779
[TBL] [Abstract][Full Text] [Related]
15. Novel triazolium based 11(th) group NHCs: synthesis, characterization and cellular response mechanisms.
Pellei M; Gandin V; Marinelli M; Orsetti A; Del Bello F; Santini C; Marzano C
Dalton Trans; 2015 Dec; 44(48):21041-52. PubMed ID: 26587827
[TBL] [Abstract][Full Text] [Related]
16. Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.
Muenzner JK; Biersack B; Kalie H; Andronache IC; Kaps L; Schuppan D; Sasse F; Schobert R
ChemMedChem; 2014 Jun; 9(6):1195-204. PubMed ID: 24648184
[TBL] [Abstract][Full Text] [Related]
17. The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer.
Scattolin T; Bortolamiol E; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Cavallo L; Dereli B; Mane MV; Nolan SP; Visentin F
Chem Commun (Camb); 2020 Oct; 56(81):12238-12241. PubMed ID: 32926011
[TBL] [Abstract][Full Text] [Related]
18. A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.
Elie BT; Pechenyy Y; Uddin F; Contel M
J Biol Inorg Chem; 2018 May; 23(3):399-411. PubMed ID: 29508136
[TBL] [Abstract][Full Text] [Related]
19. Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes.
Li Y; Liu GF; Tan CP; Ji LN; Mao ZW
Metallomics; 2014 Aug; 6(8):1460-8. PubMed ID: 24788133
[TBL] [Abstract][Full Text] [Related]
20. Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy.
Quintana M; Rodriguez-Rius A; Vellé A; Vives S; Sanz Miguel PJ; Triola G
Bioorg Med Chem; 2022 Aug; 67():116814. PubMed ID: 35598528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
